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Evidence for enzyme catalysed intramolecular
[4+2] Diels–Alder cyclization during the
biosynthesis of pyrichalasin H†
Verena Hantke,* Elizabeth J. Skellam and Russell J. Cox *
Cytochalasans are highly complex fungal metabolites which exhibit
diverse biological activities. Little is known of the chemical steps
involved in the construction of the tricyclic core, which consists of an
octahydro-isoindole skeleton fused to a macrocyclic ring. Here, using a
directed gene knockout and complementation strategy, we show that
PyiF is implicated as the proposed intramolecular [4+2] Diels–Alderase
required for construction of the tricyclic core of pyrichalasin H 1.
Cytochalasans are a diverse group of fungal polyketide-non-
ribosomal peptide secondary metabolites with varied biological
properties including antibacterial, antiviral and antitumor
potential.1,2 All cytochalasans contain a tricyclic core, which
consists of a macrocyclic ring fused to an amino acid-derived
octahydro-isoindole. Differences arise from variations in the
size and the substitution pattern of the macrocycle and the
incorporated amino acid (Fig. 1).3
Several biosynthetic gene clusters (BGC) involved in cyto-
chalasan biosynthesis are known, and their biosynthetic pathways
have been partially elucidated, including those for pyrichalasin
H 1,4 cytochalasin E 2,5 chaetoglobosin A 36 and compounds
such as niduporthin 47 and the ACE1 shunt 58 which are
genetically and chemically closely related. All cytochalasan
BGC encode: a polyketide synthase/non-ribosomal peptide
synthetase (PKS-NRPS); a trans-acting enoyl reductase (ER); an
ab-hydrolase (HYD); several tailoring enzymes such as cyto-
chrome P450 monooxygenases (P450) and oxidoreductases
(OXR); and transcriptional regulators (TF) and transporters.
Recently, we identified the pyi BGC encoding the phytotoxin
pyrichalasin H 1 in Magnaporthe grisea NI980 (Scheme 1) and
elucidated the late-stage biosynthetic pathway of 1 using targeted
gene inactivations.4
Formation of the tricyclic core of 1 and other cytochalasans
is thought to occur in two steps. First, it is proposed that the
PKS-NRPS reductively releases an N-acyl a-amino aldehyde 9
which is cyclised to form a 1,5-dihydropyrrolone 10. This is
then proposed to undergo an endo-selective intramolecular
[4+2] Diels Alder (DA) reaction (Scheme 1).9 Intermediates 9
and 10 have not been observed for pyrichalasin H 1 or related
cytochalasans, although similar a-aminoaldehyde and pyrrolone
intermediates have been proposed during the biosynthesis of
fusarin C, for example.3,10 In other related systems non-reductive
release (i.e. Dieckmann cyclisation) occurs during the biosynthesis
of, e.g., pretenellin A.11 The heterocyclic core seems to be formed
by the PKS-NRPS and trans-ER alone in the cases of niduporthin
47 and cytochalasans from Parastagonospora nodorum.12
The assumption that the DA reaction is not spontaneous is
supported by observations in the total synthesis of cytochalasans.13
Stork and Nakamura developed the first biomimetic macro-
cyclization strategy in 1982 while synthesizing cytochalasin B. To
achieve the DA reaction a precursor analogous to 10 had to be
heated to 180–190 1C in neat mesitylene for nearly a week to yield
35% product (4 : 1 mixture of endo : exo), strongly suggesting that
the DA reaction is not favoured under physiological conditions.14
Enzymatic DA15 and hetero DA (hDA)16 catalysts have been
discovered and validated in several biosynthetic pathways.
However, while the action of a DA enzyme has been frequently
Fig. 1 Chemical structures of selected cytochalasans and related metabolites.
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proposed as the key element of cytochalasan pathways no
evidence has been so-far gathered for the identity of this
catalyst. In the case of pyrichalasin H 1 we have recently
demonstrated the function of all the genes in its BGC except
pyiE and pyiF.4 Homologs of these two genes are present in
all known cytochalasan BGC and they may thus be involved
in the formation of the isoindole. PyiE is a member of the
ab-hydrolase family,17 but PyiF and its homologs have no
known function. Here we investigated the function of PyiF
and homologs from other systems by knockout (KO) and
complementation in M. grisea NI980.
Disruption of pyiF was achieved by replacing it with a
hygromycin resistance cassette.18 Wild-type (WT) M. grisea
NI980 produces 1 at around 60 mg L1 (Fig. 2A), but inactivation
of pyiF resulted in the abolition of 1 (Fig. 2B).
We expected knockout of pyiF to result in an accumulation
of the pyrrolone 10 (m/z = 447 g mol1) but this was not observed.
Instead the organic extracts of DpyiF strains contained several
new compounds which, based on their UV absorption spectra at
275 nm (see ESI†), derived from tyrosine 6 or O-methyl tyrosine 7
(Fig. 1B). Eight compounds (15, 0.4 mg; 21, 0.3 mg; 20 and 17
(mixture, 20 : 17 ca. 2 : 1), 0.5 mg; 19 and 14 (mixture, 19 : 14
ca. 1 : 1.2), 1.5 mg; 16, 0.5 mg; and 18, 1.0 mg) were purified by
preparative LCMS from a 1 litre DpyiF M. grisea culture after
7 days.
The molecular formula for each compound was obtained
(HRMS) and structure elucidation (NMR, see ESI† for full NMR
and HRMS data) was then performed. In the case of the
major compound 14, HRMS indicated a molecular formula of
C29H43NO6 (obs. 546.3073, calc., 546.3067, ES
, [M + HCO2H–H]
)
consistent with the skeleton of 1. HMBC correlations from the
methoxy group (dH 3.7 ppm) to C-27, supported by HMBC from
H-25 and H-26, confirmed the presence of the p-substituted
aromatic ring and also located benzylic C-23 (dC 39.7 ppm). COSY
correlation from H-23 via H-5, H-4 and H-3 led to methine H-6,
and HMBC from H-4 and H-5 located C-2 (dC 177.2 ppm) and
confirmed the presence of the g-lactam. Further COSY correla-
tions then located the 7/8 olefin, and methine H-9 and methylenes
H-10. HMBC correlations to methyls 21 and 22 located carbons
8–12, and further COSY correlations then revealed the diene
system to C-16. Finally, HMBC from methyls-19 and 20 revealed
C-17 as a tertiary alcohol and C-18 as a secondary alcohol
(Scheme 2B). The related compounds were identified by
comparison and close analysis of HMBC signals, particularly
around the g-lactam.
All isolated compounds displayed an underlying linear
structure of the polyketide moiety. The C-17/C-18 olefin was
dihydroxylated in all compounds, probably via epoxide forma-
tion and hydrolysis. Genome analysis of M. grisea showed it
contains the dihydropyriculol/dihydropyriculariol 22/23 BGC19
and dihydropyriculol 22 was purified and characterised from
M. grisea NI980 producing strains (see ESI†). The same oxygenase
responsible for the formation of the diols in 22/23 could give the
diols observed in 14–21.
Compound 21 also features C-13/C-14 olefin dihydroxylation;
compounds 14 and 15 are hydroxyled at C-4; and compound 20
is hydroxylated at C-11. Another deviation from the expected
pyrrolone 10 is that all compounds carry a hydroxyl at C-6
instead of a carbonyl. Furthermore, the C-3/C-4 olefin of 10
(part of the pyrrolone ring) is missing in all compounds, except
16 and 17. Five compounds (14, 16, 18, 20, 21) derive from
O-methyl tyrosine 7; the others from tyrosine 6. The observed
compounds appeared to be shunt products of 10 (or its 27-O-
desmethyl cogener) formed via oxidative and reductive steps.
A functional copy of pyiF was then introduced downstream
of the inducible amyB promoter (PamyB) from Aspergillus oryzae
and transformed into two DpyiF M. grisea strains.
As expected, in all strains carrying an ectopic functional copy
of pyiF, the production of 1 was restored. However, the obtained
yields of 1 were lower compared to the wild type (ca. 10%).
In addition, some of the shunt intermediates (14–21) observed in
Scheme 1 Proposed early biosynthetic steps of pyrichalasin H 1.
Fig. 2 LCMS traces (diode array) for key experiments: (A) M. grisea wild type
(WT); (B) M. grisea DpyiF; (C) as B, complemented with pyiF; (D) as B,





































































































This journal is©The Royal Society of Chemistry 2020 Chem. Commun., 2020, 56, 2925--2928 | 2927
the DpyiF M. grisea deletion strain were also detected in most of
the transformants (mainly compound 14, Fig. 2C).
Heterologous complementation studies were carried out to
investigate if the closely related homologous protein ORF3
(62% identity to PyiF, see ESI†) from the cryptic ACE1 BGC in
P. oryzae Guy11,20 is able to restore production of 1. The pyi and
ACE1 gene clusters are closely related, suggesting that ORF3
might be able to replace PyiF as a DAase. This was confirmed
when DpyiF M. grisea strains carrying ORF3 driven by PamyB
restored the production of 1, albeit in similar titres compared
to the homologous complementation with pyiF (ca. 10%, Fig. 2D).
No new compounds were observed.
An analogous complementation experiment was also carried
out with the poxQ gene from Penicillium oxalicum. PoxQ is
proposed to be a decalin-forming DAase (29% identical to PyiF)
during the biosynthesis of oxaleimide.21 PoxQ and related
enzymes22 are proposed to intercept an intermediate 24 in
which the polyketide moiety is nearly identical to that proposed
in the case of pyrichalasin H 1 (e.g. 8, Scheme 2D). If the PoxQ
protein recognised 8 then decalins such as 26 might be
expected. However, all M. grisea DpyiF:PamyBPoxQ transformants
demonstrated the same secondary metabolite profile as the
M. grisea DpyiF control strain (Fig. 2E). Accordingly, the production
of 1 could not be restored and no new decalin-containing
compounds were produced.
Finally, in an attempt to demonstrate in vitro activity
of PyiF very extensive efforts were made to obtain soluble
PyiF protein via heterologous expression. However this proved
impossible.
In conclusion, targeted gene disruption of pyiF in M. grisea
resulted in complete abolition of 1, and the accumulation of
14–21 which appear to arise from a redox shunt pathway from
10 (Scheme 2). Compound 16 probably arises by reduction of
the C-6 carbonyl and likely epoxidation and hydrolysis of the
C-17/18 olefin. Conjugate addition of water at C-4/5 could then
give the main compound 14. Further reduction of 16 leads
to compound 18, and compounds 20 and 22 are oxidation
products of 18. Dihydroxylation of the triene sidechain may be
catalysed by enzymes from the pyriculol pathway, known to be
present and active in M. grisea. Compounds 15, 17 and 19
lacking the O-methyl likely arise from use of tyrosine by the
PyiS NRPS.18
All compounds isolated from the DpyiF mutant lack the
cyclohexenyl moiety indicating that the DA reaction has not
occurred. This, therefore, shows that PyiF is the likely DA
enzyme required for the formation of the core cytochalasan
isoindole. Complementation studies showed that the closely
related ORF3 (62% identical) from the cryptic ACE1 pathway is
also a DA enzyme, and since all known cytochalasan BGCs
contain a homolog of pyiF/ORF3, the results suggest this is the
likely function of these genes. The results of this experiment
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also add to the growing evidence that the cryptic ACE1 metabolite
is a cytochalasan.18
It is notable that the titres of the DA products from the
complementation experiments are lower than the WT titres of 1.
This most likely arises because the A. oryzae PamyB promoter, used
to drive the expression in these cases, is not strong when used in
M. grisea.23 Lebrun and coworkers showed in a previous study that
ORF3 is the most highly expressed gene in the ACE1 BGC, perhaps
indicating a requirement for relatively high protein concentrations
for rapid DA reaction.24
Heterologous complementation of the DpyiF mutant with
poxQ from Penicillium oxalicum did not restore the production
of 1, or produce a decalin metabolite. PoxQ is proposed to catalyse a
decalin forming DA reaction of a near-identical polyketide inter-
mediate (e.g. 8) during the biosynthesis of 1 (Scheme 2D).19 This may
indicate that PoxQ and related decalin-forming catalysts20 recognise
more than just the polyketide intermediates, or that the triene of 8
was rapidly destroyed by olefin oxidation before PoxQ could act.
Intermediates such as 8 are also known to undergo spontaneous
decalin formation (albeit with different stereoselectivity)20 and rapid
conversion of 8 to 14 in M. grisea could also explain the lack of
spontaneous decalin formation.
Collectively, our results strongly suggest that PyiF and ORF3
catalyse the long-proposed intramolecular DA reaction forming
the tricyclic core structure of cytochalasans. For the first time the
involvement of a DA enzyme in the biosynthesis of cytochalasans
has been experimentally confirmed. DA enzymes involved in the
biosynthesis of cytochalasans belong to the stand-alone class of
pericyclases with no additional function besides catalysing the
[4+2] cyclisation. Whether this reaction requires conformational
or chemical catalysis is unknown and will require in vitro studies
of soluble protein which is not yet available. To gain more
insights into the biosynthetic role of the hydrolase PyiE,
in vitro studies are underway and results of these experiments
will be reported in due course.25
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